Targeted therapy for head and neck cancer: signaling pathways and clinical studies
Head and neck cancer (HNC) is malignant, genetically complex and difficult to treat and is
the sixth most frequent cancer, with tobacco, alcohol and human papillomavirus being major …
the sixth most frequent cancer, with tobacco, alcohol and human papillomavirus being major …
Proliferation and apoptosis pathways and factors in oral squamous cell carcinoma
S He, R Chakraborty, S Ranganathan - International journal of molecular …, 2022 - mdpi.com
Oral cancer is the most common form of head and neck squamous cell carcinoma (HNSCC)
and most frequently presents as oral squamous cell carcinoma (OSCC), which is associated …
and most frequently presents as oral squamous cell carcinoma (OSCC), which is associated …
M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop
Y You, Z Tian, Z Du, K Wu, G Xu, M Dai, Y Wang… - Journal of Experimental …, 2022 - Springer
Abstract Background Tumor-associated macrophages (TAMs) have a leading position in the
tumor microenvironment. Previously, we have demonstrated that M1-like TAMs activated by …
tumor microenvironment. Previously, we have demonstrated that M1-like TAMs activated by …
[HTML][HTML] Role of E2F transcription factor in oral cancer: Recent insight and advancements
A Kassab, I Gupta, AE Al Moustafa - Seminars in cancer biology, 2023 - Elsevier
The family of mammalian E2F transcription factors (E2Fs) comprise of 8 members (E2F1-
E2F8) classified as activators (E2F1-E2F3) and repressors (E2F4-E2F8) primarily regulating …
E2F8) classified as activators (E2F1-E2F3) and repressors (E2F4-E2F8) primarily regulating …
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells
In heterogeneous head and neck cancer (HNC), subtype-specific treatment regimens are
currently missing. An integrated analysis of patient HNC subtypes using single-cell …
currently missing. An integrated analysis of patient HNC subtypes using single-cell …
Current and emerging molecular therapies for head and neck squamous cell carcinoma
F Kordbacheh, CS Farah - Cancers, 2021 - mdpi.com
Simple Summary Next-generation sequencing of head and neck squamous cell carcinoma
has revealed multiple new gene mutations, while simultaneously confirming the role of …
has revealed multiple new gene mutations, while simultaneously confirming the role of …
Relationship between tumor budding and partial epithelial–mesenchymal transition in head and neck cancer
K Okuyama, K Suzuki, S Yanamoto - Cancers, 2023 - mdpi.com
Simple Summary In this article, we outline updates on the current relevance of tumor
budding (TB) and partial epithelial–mesenchymal transition (p-EMT), both as a prognostic …
budding (TB) and partial epithelial–mesenchymal transition (p-EMT), both as a prognostic …
A novel preclinical in vitro 3D model of oral carcinogenesis for biomarker discovery and drug testing
RT Chitturi Suryaprakash, K Shearston… - International Journal of …, 2023 - mdpi.com
This study aimed to develop an in vitro three-dimensional (3D) cell culture model of oral
carcinogenesis for the rapid, scalable testing of chemotherapeutic agents. Spheroids of …
carcinogenesis for the rapid, scalable testing of chemotherapeutic agents. Spheroids of …
Implications of oral dysbiosis and HPV infection in head and neck cancer: from molecular and cellular mechanisms to early diagnosis and therapy
M Constantin, MC Chifiriuc, G Mihaescu… - Frontiers in …, 2023 - frontiersin.org
Head and neck cancer (HNC) is the sixth most common type of cancer, with more than half a
million new cases annually. This review focuses on the role of oral dysbiosis and HPV …
million new cases annually. This review focuses on the role of oral dysbiosis and HPV …
Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications
Head and neck squamous cell carcinoma (HNSCC) are among the well-known neoplasms
originating in the oral cavity, pharynx, and larynx. Despite advancements in chemotherapy …
originating in the oral cavity, pharynx, and larynx. Despite advancements in chemotherapy …